A detailed history of Headlands Technologies LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Headlands Technologies LLC holds 2,472 shares of PRTA stock, worth $33,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,472
Previous 1,675 47.58%
Holding current value
$33,396
Previous $34,000 20.59%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$16.73 - $24.79 $13,333 - $19,757
797 Added 47.58%
2,472 $41,000
Q2 2024

Aug 07, 2024

SELL
$19.54 - $26.15 $43,105 - $57,686
-2,206 Reduced 56.84%
1,675 $34,000
Q1 2024

May 07, 2024

BUY
$24.75 - $40.66 $96,054 - $157,801
3,881 New
3,881 $96,000
Q3 2023

Nov 09, 2023

BUY
$47.3 - $70.6 $72,416 - $108,088
1,531 New
1,531 $73,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $634M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.